PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9129045-9	1997	Protein kinase C (PKC) activation with 100 nmol/L TPA (12-O-tetradecanoylphorbol 13-acetate) or incubation with interleukin-4 (10 ng/mL) prevented either dexamethasone- or fludarabine-induced proteolysis of PARP.	fludarabine	172-183	interleukin 4	Homo sapiens	112-125	
22072733-13	2012	CONCLUSION: We thus show that A771726 overcomes CD40L/IL-4-mediated resistance to fludarabine in CLL cells of untreated as well as clinically refractory CLL cells.	fludarabine	82-93	interleukin 4	Homo sapiens	54-58	
20716767-5	2010	A dye reduction cytotoxicity assay showed that IL-4 induced resistance to the cytotoxic drugs fludarabine and chlorambucil and to the novel p53-elevating agent nutlin 3.	fludarabine	94-105	interleukin 4	Homo sapiens	47-51	
18078872-7	2008	We found that the acute stimulation of PKC in IL-4-treated CLL cells by short-term incubation with PMA significantly increased hENT1 transport activity and favoured fludarabine-induced apoptosis.	fludarabine	165-176	interleukin 4	Homo sapiens	46-50	
18078872-9	2008	Our findings indicate that the combined treatment with IL-4 and PMA enhances hENT1 activity and specifically sensitizes CLL cells to undergo apoptosis induced by fludarabine.	fludarabine	162-173	interleukin 4	Homo sapiens	55-59	
20306682-0	2008	Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.	fludarabine	28-39	interleukin 4	Homo sapiens	14-18	
11260081-6	2001	Fludarabine (F-ara-AMP, 0.1-100 micromol/ml) was able to downregulate the IL-4 content of CD8+ T cells, but not clonal B-cell IL-4.	fludarabine	0-11	interleukin 4	Homo sapiens	74-78